Twelve-year survival and immune correlates in dendritic cell–vaccinated melanoma patients

Background. Reports on long-term (≥10 years) effects of cancer vaccines are missing. Therefore, in 2002, we initiated a phase I/II trial in cutaneous melanoma patients to further explore the immunogenicity of our DC vaccine and to establish its long-term toxicity and clinical benefit after a planned...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JCI Insight
Auteurs principaux: Gross, Stefanie, Erdmann, Michael, Haendle, Ina, Voland, Steve, Berger, Thomas, Schultz, Erwin, Strasser, Erwin, Dankerl, Peter, Janka, Rolf, Schliep, Stefan, Heinzerling, Lucie, Sotlar, Karl, Coulie, Pierre, Schuler, Gerold, Schuler-Thurner, Beatrice
Format: Artigo
Langue:Inglês
Publié: American Society for Clinical Investigation 2017
Sujets:
Clinical Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5396520/
https://ncbi.nlm.nih.gov/pubmed/28422751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.91438
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires